J Pater
Overview
Explore the profile of J Pater including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
2364
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Osoba D, Rodrigues G, Myles J, Zee B, Pater J
J Clin Oncol
. 2023 Dec;
41(35):5345-5350.
PMID: 38056079
Purpose: To determine the significance to patients of changes in health-related quality-of-life (HLQ) scores assessed by the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire...
2.
Abed Abud A, Abi B, Acciarri R, Acero M, Adames M, Adamov G, et al.
Eur Phys J C Part Fields
. 2022 Jul;
82(7):618.
PMID: 35859696
DUNE is a dual-site experiment for long-baseline neutrino oscillation studies, neutrino astrophysics and nucleon decay searches. ProtoDUNE Dual Phase (DP) is a 6 6 6 m liquid argon time-projection-chamber (LArTPC)...
3.
Abi B, Acciarri R, Acero M, Adamov G, Adams D, Adinolfi M, et al.
Eur Phys J C Part Fields
. 2021 Nov;
81(4):322.
PMID: 34720713
The Deep Underground Neutrino Experiment (DUNE) will be a powerful tool for a variety of physics topics. The high-intensity proton beams provide a large neutrino flux, sampled by a near...
4.
Acciarri R, Adams C, Andreopoulos C, Asaadi J, Babicz M, Backhouse C, et al.
Front Artif Intell
. 2021 Sep;
4:649917.
PMID: 34505055
In liquid argon time projection chambers exposed to neutrino beams and running on or near surface levels, cosmic muons, and other cosmic particles are incident on the detectors while a...
5.
Loaiza P, Barabash A, Basharina-Freshville A, Birdsall E, Blondel S, Blot S, et al.
Appl Radiat Isot
. 2017 Mar;
123:54-59.
PMID: 28242294
The BiPo-3 detector is a low radioactive detector dedicated to measuring ultra-low natural contaminations of Tl and Bi in thin materials, initially developed to measure the radiopurity of the double...
6.
Pater J, Rochon J, Parmar M, Selby P
Ann Oncol
. 2011 Nov;
22 Suppl 7:vii57-vii61.
PMID: 22039148
This supplement has explored the evidence for benefits from the participation of healthcare institutions and their patients in clinical research. The questions have been clarified. There is some encouragement that...
7.
Bradbury P, Meyer R, Pater J, Tu D, Seymour L, Shepherd L, et al.
Ann Oncol
. 2009 Jan;
20(2):395-6.
PMID: 19150952
No abstract available.
8.
Ding K, Pater J, Whitehead M, Seymour L, Shepherd F
Contemp Clin Trials
. 2008 Feb;
29(4):527-36.
PMID: 18280222
The target of novel signal transduction inhibitors may be present on normal as well as tumor cells, resulting in mechanistic adverse effects (AE) in addition to antitumor activity. As those...
9.
Dimasi D, Hewitt A, Straga T, Pater J, MacKinnon J, Elder J, et al.
Clin Genet
. 2007 Aug;
72(3):255-60.
PMID: 17718864
Analysis of CYP1B1 in primary congenital glaucoma (PCG) patients from various ethnic populations indicates that allelic heterogeneity is high, and some mutations are population specific. No study has previously reported...
10.
Richardson H, Johnston D, Pater J, Goss P
Curr Oncol
. 2007 Jun;
14(3):89-96.
PMID: 17593981
Several large phase III trials have demonstrated that tamoxifen-and more recently, raloxifene-can effectively reduce the incidence of invasive breast cancer by 50%. However, these selective estrogen receptor modulators can also...